Skip to content
HowShorted

Cardiff Oncology, Inc. short interest in 2026

In 2026, Cardiff Oncology, Inc.'s disclosed short interest ran from 24.07% of shares outstanding on 15 Jan 2026 to 15.82% on 15 Sep 2026, a change of -8.25 percentage points. The year's high was 27.20% on 15 Apr 2026 and its low 15.02% on 31 Aug 2026, averaging 22.70% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.33 days on 31 Mar 2026. Full history: Cardiff Oncology, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Cardiff Oncology, Inc. in 2026

2026 in figures

Start of year
24.07% (15 Jan 2026)
End of year
15.82% (15 Sep 2026)
Change
-8.25 pp
High
27.20% (15 Apr 2026)
Low
15.02% (31 Aug 2026)
Average
22.70%
Highest days to cover
32.33 (31 Mar 2026)
SEC filings marked
5

Every report in 2026

Cardiff Oncology, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202624.07%17.48
30 Jan 202625.52%6.35
13 Feb 202626.69%21.31
27 Feb 202626.25%23.4610-K filed
13 Mar 202625.86%27.04
31 Mar 202626.60%32.33
15 Apr 202627.20%22.21
30 Apr 202626.87%29.02
15 May 202626.35%26.8810-Q filed, results (8-K)
29 May 202626.52%12.28
15 Jun 202623.62%7.96
30 Jun 202618.74%7.76
15 Jul 202617.68%6.16
31 Jul 202617.84%9.26
14 Aug 202615.29%15.2710-Q filed, results (8-K)
31 Aug 202615.02%18.16
15 Sep 202615.82%12.06

See also: Cardiff Oncology, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.